Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-Hydroxymethyl-Piperidine-1,4-Dicarboxylic Acid 1-Tert-Butyl Ester 4-Methyl Ester is a complex organic compound with the molecular formula C14H23NO6. It is a derivative of piperidine, a heterocyclic amine, and features two carboxylic acid groups, one hydroxymethyl group, and two ester groups. The compound is characterized by the presence of a tert-butyl ester group at the 1-position and a methyl ester group at the 4-position. This chemical is primarily used as an intermediate in the synthesis of various pharmaceuticals and other organic compounds. Its structure provides a versatile platform for further chemical modifications, making it a valuable building block in organic chemistry and drug development.

1006044-27-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1-O-tert-butyl 4-O-methyl 4-(hydroxymethyl)piperidine-1,4-dicarboxylate

    Cas No: 1006044-27-4

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 1006044-27-4 Structure
  • Basic information

    1. Product Name: 4-Hydroxymethyl-Piperidine-1,4-Dicarboxylic Acid 1-Tert-Butyl Ester 4-Methyl Ester
    2. Synonyms: 4-Hydroxymethyl-Piperidine-1,4-Dicarboxylic Acid 1-Tert-Butyl Ester 4-Methyl Ester;4-Hydroxymethyl-Piperidine-1,4-Dicarboxylic Acid 1-Tert-Butyl Ester 4-Methyl Ester(WX640222);1-TERT-BUTYL 4-METHYL 4-(HYDROXYMETHYL)PIPERIDINE-1,4-DICARBOXYLATE
    3. CAS NO:1006044-27-4
    4. Molecular Formula: C13H23NO5
    5. Molecular Weight: 274.33336
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1006044-27-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 361.5±27.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.142±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 14.94±0.10(Predicted)
    10. CAS DataBase Reference: 4-Hydroxymethyl-Piperidine-1,4-Dicarboxylic Acid 1-Tert-Butyl Ester 4-Methyl Ester(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-Hydroxymethyl-Piperidine-1,4-Dicarboxylic Acid 1-Tert-Butyl Ester 4-Methyl Ester(1006044-27-4)
    12. EPA Substance Registry System: 4-Hydroxymethyl-Piperidine-1,4-Dicarboxylic Acid 1-Tert-Butyl Ester 4-Methyl Ester(1006044-27-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1006044-27-4(Hazardous Substances Data)

1006044-27-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1006044-27-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,6,0,4 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1006044-27:
(9*1)+(8*0)+(7*0)+(6*6)+(5*0)+(4*4)+(3*4)+(2*2)+(1*7)=84
84 % 10 = 4
So 1006044-27-4 is a valid CAS Registry Number.

1006044-27-4Downstream Products

1006044-27-4Relevant articles and documents

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

-

Paragraph 0688; 0689, (2015/09/22)

The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.

Synthesis of novel substituted 3,8,11-triazaspiro[5,6]dodecan-7-ones

Qin, Lan-Ying,Cole, Andrew G.,Metzger, Axel,Saionz, Kurt W.,Henderson, Ian

scheme or table, p. 849 - 852 (2011/03/20)

A synthesis of novel substituted 3,8,11-triazaspiro[5,6]dodecan-7-ones using a combination of solution-phase and solid-phase chemistries is described. A solution-phase approach was used to produce a key piperidine intermediate that was then incorporated into a solid-phase synthesis. The combined synthetic strategy was applied to provide a series of substituted 3,8,11-triazaspiro[5,6] dodecan-7-ones in good yield and high purity.

Certain Chemical Entities, Compositions and Methods

-

Page/Page column 14, (2009/10/30)

Chemical entities that modulate smooth muscle myosin and/or non-muscle myosin, pharmaceutical compositions and methods of treatment of diseases and conditions associated with smooth muscle myosin and/or non-muscle myosin are described.

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

-

Page/Page column 119-120, (2008/06/13)

Chemical entities that modulate smooth muscle myosin and/or non-muscle myosin, pharmaceutical compositions and methods of treatment of diseases and conditions associated with smooth muscle myosin and/or non-muscle myosin are described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1006044-27-4